469
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Enhancement of the aqueous solubility and permeability of a poorly water soluble drug ritonavir via lyophilized milk-based solid dispersions

, , , , &
Pages 90-102 | Received 31 Mar 2016, Accepted 21 Apr 2016, Published online: 13 Jun 2016

References

  • Kesisoglou F, Panmai S, Wu Y. Nanosizing-oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev 2007;59:631–644.
  • Shukla D, Chakraborty S, Singh S, Mishra B. Lipid-based oral multiparticulate formulations – advantages, technological advances and industrial applications. Expert Opin Drug Deliv 2011;8:207–224.
  • Liu H, Edgar KJ. Synthesis and characterization of neutral and anionic cellulosic amphiphiles. Carbohydr Polym 2014;113:480–489.
  • Liu H, Ilevbare GA, Cherniawski BP, et al. Synthesis and structure–property evaluation of cellulose ω-carboxyesters for amorphous solid dispersions. Carbohydr Polym 2014;100:116–125.
  • Yu LX, Amidon GL, Polli JE, et al. Biopharmaceutics classification system: the scientific basis for biowaiver extensions. Pharm Res 2002;19:921–925.
  • Kawabata Y, Wada K, Nakatani M, et al. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int J Pharm 2011;420:1–10.
  • Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today 2007;12:1068–1075.
  • Blagden N, de Matas M, Gavan PT, York P. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Deliv Rev 2007;59:617–630.
  • Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50:47–60.
  • Berge SM, Bighley LD, Monkhouse DC. Pharmaceutical salts. J Pharm Sci 1977;66:1–19.
  • Fatouros D, Deen GR, Arleth L, et al. Structural development of self nano emulsifying drug delivery systems (SNEDDS) during in vitro lipid digestion monitored by small-angle X-ray scattering. Pharm Res 2007;24:1844–1853.
  • Lavasanifar A, Samuel J, Kwon GS. Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery. Adv Drug Deliv Rev 2002;54:169–190.
  • Loftsson T, Duchêne D. Cyclodextrins and their pharmaceutical applications. Int J Pharm 2007;329:1–11.
  • Mueller E, Kovarik J, van Bree J, et al. Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation. Pharm Res 1994;11:301–304.
  • Müller RH, Peters K. Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique. Int J Pharm 1998;160:229–237.
  • Park JH, Choi HK. Enhancement of solubility and dissolution of cilostazol by solid dispersion technique. Arch Pharm Res 2015;38:1336–1344.
  • Potta SG, Minemi S, Nukala RK, et al. Development of solid lipid nanoparticles for enhanced solubility of poorly soluble drugs. J Biomed Nanotechnol 2010;6:634–640.
  • Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov 2004;3:785–796.
  • Rautio J, Kumpulainen H, Heimbach T, et al. Prodrugs: design and clinical applications. Nat Rev Drug Discov 2008;7:255–270.
  • Saoji SD, Raut NA, Dhore PW, et al. Preparation and evaluation of phospholipid-based complex of standardized centella extract (SCE) for the enhanced delivery of phytoconstituents. AAPS J 2016;18:102–114.
  • Khan J, Saraf S, Saraf S. Preparation and evaluation of luteolin-phospholipid complex as an effective drug delivery tool against GalN/LPS induced liver damage . Pharm Dev Technol 2016;21:475–486.
  • Puntawee S, Theerasilp M, Reabroi S, et al. Solubility enhancement and in vitro evaluation of PEG-b-PLA micelles as nanocarrier of semi-synthetic andrographolide analogue for cholangiocarcinoma chemotherapy. Pharm Dev Technol 2016;21:437–444.
  • Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci 1971;60:1281–1302.
  • Karavas E, Georgarakis E, Sigalas MP, et al. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug–polymer interactions. Eur J Pharm Biopharm 2007; 66:334–347.
  • Bikiaris D, Papageorgiou GZ, Stergiou A, et al. Physicochemical studies on solid dispersions of poorly water-soluble drugs: evaluation of capabilities and limitations of thermal analysis techniques. Thermochim Acta 2005;439:58–67.
  • Al-Hamidi H, Edwards AA, Mohammad MA, Nokhodchi A. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations. Colloids Surf B Biointerfaces 2010;76:170–178.
  • Lea AP, Faulds D. Ritonavir. Drugs 1996;52:541–546. discussion 547–548.
  • de Kruif CG. Casein micelle interactions. Int Dairy J 1999;9:183–188.
  • Portnaya I, Ben-Shoshan E, Cogan U, et al. Self-assembly of bovine beta-casein below the isoelectric pH. J Agric Food Chem 2008;56:2192–2198.
  • Dauphas S, Mouhous-Riou N, Metro B, et al. The supramolecular organisation of β-casein: effect on interfacial properties. Food Hydrocolloids 2005;19:387–393.
  • Mikheeva LM, Grinberg NV, Grinberg VY, et al. Thermodynamics of micellization of bovine β-casein studied by high-sensitivity differential scanning calorimetry. Langmuir 2003;19:2913–2921.
  • Sahin NO, Arslan H. Inclusion complex of prednisolone with skimmed milk. Part I: physicochemical characterization. Yakugaku Zasshi 2007;127:1255–1261.
  • Law D, Schmitt EA, Marsh KC, et al. Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluations. J Pharm Sci 2004;93:563–570.
  • Sinha S, Ali M, Baboota S, et al. Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir. AAPS PharmSciTech 2010;11:518–527.
  • Anton Girones M, Roan Roan J, de la Hoz B, Sanchez Cano M. Immediate allergic reactions by polyethylene glycol 4000: two cases. Allergol Immunopathol (Madr) 2008;36:110–112.
  • Shelanski HA. PVP K-30 14C single dose excretion study – unpublished report from the Industrial Toxicology Laboratories United States of America. Submitted to the World Health Organization by BASF; 1953.
  • Shelanski HA. Final two-year report of a chronic oral toxicity study with PVP (K-30) in rats. Unpublished report from the Industrial Biological Research and Testing Laboratories, United States of America. Submitted to the World Health Organization by BASF; 1957.
  • Choudhary A, Rana AC, Aggarwal G, et al. Development and characterization of an atorvastatin solid dispersion formulation using skimmed milk for improved oral bioavailability. Acta Pharm Sin B 2012;2:421–428.
  • Sonar PA, Behera AL, Banerjee SK, et al. Preparation and characterization of Simvastatin solid dispersion using skimmed milk. Drug Dev Ind Pharm 2015;41:22–27.
  • Topaloğlu Y, Yener G, Gönüllü Ü. Inclusion of ketoprofen with skimmed milk by freeze-drying. Il Farmaco 1999;54:648–652.
  • Sze A, Erickson D, Ren L, Li D. Zeta-potential measurement using the Smoluchowski equation and the slope of the current-time relationship in electroosmotic flow. J Colloid Interface Sci 2003;261:402–410.
  • Saoji S, Atram S, Dhore P, et al. Influence of the component excipients on the quality and functionality of a transdermal film formulation. AAPS PharmSciTech 2015;16:1344–1356.
  • Gupta P, Kakumanu V, Bansal A. Stability and solubility of Celecoxib-PVP amorphous dispersions: a molecular perspective. Pharm Res 2004;21:1762–1769.
  • Zhang Y, Huo M, Zhou J, et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J 2010;12:263–271.
  • Anderson NH, Bauer M, Boussac N, et al. An evaluation of fit factors and dissolution efficiency for the comparison of in vitro dissolution profiles. J Pharm Biomed Anal 1998;17:811–822.
  • Sekar V, Kestens D, Spinosa-Guzman S, et al. The effect of different meal types on the pharmacokinetics of darunavir (TMC114)/ritonavir in HIV-negative healthy volunteers. J Clin Pharmacol 2007;47:479–484.
  • Klein S. The use of biorelevant dissolution media to forecast the in vivo performance of a drug. AAPS J 2010;12:397–406.
  • Dixit P, Jain DK, Dumbwani J. Standardization of an ex vivo method for determination of intestinal permeability of drugs using everted rat intestine apparatus. J Pharmacol Toxicol Methods 2012;65:13–17.
  • Bouma M, Nuijen B, Sava G, et al. Pharmaceutical development of a parenteral lyophilized formulation of the antimetastatic ruthenium complex NAMI-A. Int J Pharm 2002;248:247–259.
  • Sudhakar B, Krishna M, Murthy K. Factorial design studies of antiretroviral drug-loaded stealth liposomal injectable: PEGylation, lyophilization and pharmacokinetic studies. Appl Nanosci 2016;43–60.
  • Morissette SL, Soukasene S, Levinson D, et al. Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization. Proc Natl Acad Sci USA 2003;100:2180–2184.
  • Rarokar NR, Saoji SD, Raut NA, et al. Nanostructured cubosomes in a thermoresponsive depot system: an alternative approach for the controlled delivery of docetaxel. AAPS PharmSciTech 2016;17:436–436.
  • LeFevre ME, Olivo R, Vanderhoff JW, Joel DD. Accumulation of latex in Peyer's patches and its subsequent appearance in villi and mesenteric lymph nodes. Proc Soc Exp Biol Med 1978;159:298–302.
  • Savić R, Luo L, Eisenberg A, Maysinger D. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 2003;300:615–618.
  • Freitas C, Müller RH. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions. Int J Pharm 1998;168:221–229.
  • Vo CL-N, Park C, Lee B-J. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. Eur J Pharm Biopharm 2013;85:799–813.
  • Pandya R, Mehta T, Gohel M. Amalgamation of solid dispersion and adsorption technique. J Therm Anal Calorim 2015;120:699–709.
  • Vijaya Kumar SG, Mishra DN. Preparation and evaluation of solid dispersion of meloxicam with skimmed milk. Yakugaku Zasshi 2006;126:93–97.
  • Simonelli AP, Mehta SC, Higuchi WI. Dissolution rates of high energy polyvinylpyrrolidone (PVP)-sulfathiazole coprecipitates. J Pharm Sci 1969;58:538–549.
  • Patel BB, Patel JK, Chakraborty S. Solubility enhancement using poly(meth)acrylate based solid dispersions. Powder Technol 2015;270:27–38.
  • Patel M, Tekade A, Gattani S, Surana S. Solubility enhancement of lovastatin by modified locust bean gum using solid dispersion techniques. AAPS PharmSciTech 2008;9:1262–1269.
  • Zecevic DE, Meier R, Daniels R, Wagner K-G. Site specific solubility improvement using solid dispersions of HPMC-AS/HPC SSL-mixtures. Eur J Pharm Biopharm 2014;87:264–270.
  • Diker B, Janneh O, van Heeswijk RP, Copeland KF. Comparative efflux of saquinavir, ritonavir and lopinavir from primary human cells. Drug Metab Lett 2010;4:241–245.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.